Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients
DOI:
https://doi.org/10.2340/actadv.v104.12373Keywords:
cicatricial alopecia, hair follicle, hair tufting, scarring hair loss, trichoscopyAbstract
Folliculitis decalvans and lichen planopilaris phenotypic spectrum has been described as a form of cicatricial alopecia. The aim of this study is to describe the clinical and trichoscopic features and therapeutic management of this condition in a series of patients. A retrospective observational unicentre study was designed including patients with folliculitis decalvans and lichen planopilaris phenotypic spectrum confirmed with biopsy. A total of 31 patients (20 females) were included. The most common presentation was an isolated plaque of alopecia (61.3%) in the vertex. Trichoscopy revealed hair tufting with perifollicular white scaling in all cases. The duration of the condition was the only factor associated with large plaques (grade III) of alopecia (p = 0.026). The mean time to transition from the classic presentation of folliculitis decalvans to folliculitis decalvans and lichen planopilaris phenotypic spectrum was 5.2 years. The most frequently used treatments were topical steroids (80.6%), intralesional steroids (64.5%) and topical antibiotics (32.3%). Nine clinical relapses were detected after a mean time of 18 months (range 12–23 months). Folliculitis decalvans and lichen planopilaris phenotypic spectrum is an infrequent, but probably underdiagnosed, cicatricial alopecia. Treatment with anti-inflammatory drugs used for lichen planopilaris may be an adequate approach.
Downloads
References
Pindado-Ortega C, Saceda-Corralo D, Miguel-Gómez L, Buendía-Castaño D, Fernández-González P, Moreno-Arrones OM, et al. Impact of folliculitis decalvans on quality of life and subjective perception of disease. Skin Appendage Disord 2018; 4: 34-36.
https://doi.org/10.1159/000478053 DOI: https://doi.org/10.1159/000478053
Saceda-Corralo D, Moreno-Arrones OM, Rodrigues-Barata R, Rubio-Lombraña M, Mir-Bonafé JF, Morales-Raya C, et al. Trichoscopy activity scale for folliculitis decalvans. J Eur Acad Dermatol Venereol 2020; 34: e55-e57.
https://doi.org/10.1111/jdv.15900 DOI: https://doi.org/10.1111/jdv.15900
Harries MJ, Trueb RM, Tosti A, Messenger AG, Chaudhry I, Whiting DA, et al. How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol 2009; 160: 482-501.
https://doi.org/10.1111/j.1365-2133.2008.09008.x DOI: https://doi.org/10.1111/j.1365-2133.2008.09008.x
Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, Martorell-Calatayud A, Fernández-Crehuet P, Grimalt R, et al. Folliculitis decalvans: effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up. J Am Acad Dermatol 2018; 79: 878-883.
https://doi.org/10.1016/j.jaad.2018.05.1240 DOI: https://doi.org/10.1016/j.jaad.2018.05.1240
Yip L, Barrett TH, Harries MJ. Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a case series of bi-phasic clinical presentation and theories on pathogenesis. Clin Exp Dermatol 2020; 45: 63-72.
https://doi.org/10.1111/ced.13989 DOI: https://doi.org/10.1111/ced.13989
Matard B, Cavelier-Balloy B, Assouly P, Reygagne P. It has the erythema of a lichen planopilaris, it has the hyperkeratosis of a lichen planopilaris, but it is not a lichen planopilaris: about the "lichen planopilaris-like" form of folliculitis decalvans. Am J Dermatopathol 2021; 43: 235-236.
https://doi.org/10.1097/DAD.0000000000001758 DOI: https://doi.org/10.1097/DAD.0000000000001758
Egger A, Stojadinovic O, Miteva M. Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a series of 7 new cases with focus on histopathology. Am J Dermatopathol 2020; 42: 173-177.
https://doi.org/10.1097/DAD.0000000000001595 DOI: https://doi.org/10.1097/DAD.0000000000001595
Vañõ-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, Rodrigues-Barata AR, Arias-Santiago S, Serrano-Falcón C, et al. Folliculitis decalvans: a multicentre review of 82 patients. J Eur Acad Dermatology Venereol 2015; 29: 1750-1757.
https://doi.org/10.1111/jdv.12993 DOI: https://doi.org/10.1111/jdv.12993
Trüeb RM, Rezende HD, Diaz MFRG. Dynamic trichoscopy. JAMA Dermatol 2018; 154: 877-878.
https://doi.org/10.1001/jamadermatol.2018.1175 DOI: https://doi.org/10.1001/jamadermatol.2018.1175
Ramos PM, Melo DF, Lemes LR, Alcantara G, Miot HA, Lyra MR, et al. Folliculitis decalvans and lichen planopilaris phenotypic spectrum: case report of two paediatric cases. J Eur Acad Dermatol Venereol 2021; 35: e674-e676.
https://doi.org/10.1111/jdv.17379 DOI: https://doi.org/10.1111/jdv.17379
Morais KL, Martins CF, Anzai A, Valente NYS, Romiti R. Lichen planopilaris with pustules: a diagnostic challenge. Skin Appendage Disord 2018; 4: 61-66.
https://doi.org/10.1159/000478268 DOI: https://doi.org/10.1159/000478268
Rezende HD, Dias MFRG, Kempf W, Treüb RM. Linear circumscribed scleroderma-like folliculitis decalvans: yet another face of a protean condition. Int J Trichology 2018; 10: 175-179.
https://doi.org/10.4103/ijt.ijt_9_18 DOI: https://doi.org/10.4103/ijt.ijt_9_18
Lobato-Berezo A, González-Farré M, Pujol RM. Pustular frontal fibrosing alopecia: a new variant within the folliculitis decalvans and lichen planopilaris phenotypic spectrum? Br J Dermatol 2022; 186: 905-907.
https://doi.org/10.1111/bjd.20962 DOI: https://doi.org/10.1111/bjd.20962
Eyraud A, Milpied B, Thiolat D, Darrigade AS, Boniface K, Taïeb A, et al. Inflammasome activation characterizes lesional skin of folliculitis decalvans. Acta Derm Venereol 2018; 98: 570-575.
https://doi.org/10.2340/00015555-2924 DOI: https://doi.org/10.2340/00015555-2924
Doche I, Romiti R, Hordinsky MK, Valente NS. "Normal-appearing" scalp areas are also affected in lichen planopilaris and frontal fibrosing alopecia: an observational histopathologic study of 40 patients. Exp Dermatol 2020; 29: 278-281.
https://doi.org/10.1111/exd.13834 DOI: https://doi.org/10.1111/exd.13834
Pindado-Ortega C, Perna C, Saceda-Corralo D, Fernández-Nieto D, Jaén-Olasolo P, Vañó-Galván S. Frontal fibrosing alopecia: histopathological, immunohistochemical and hormonal study of clinically unaffected scalp areas. J Eur Acad Dermatol Venereol 2020; 34: e84-e85.
https://doi.org/10.1111/jdv.15977 DOI: https://doi.org/10.1111/jdv.15977
Asfour L, Harries M. Folliculitis decalvans in the era of antibiotic resistance: microbiology and antibiotic sensitivities in a tertiary hair clinic. Int J Trichology 2020; 12: 193-194d.
https://doi.org/10.4103/ijt.ijt_98_20 DOI: https://doi.org/10.4103/ijt.ijt_98_20
Powell JJ, Dawber RPR, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999; 140: 328-333.
https://doi.org/10.1046/j.1365-2133.1999.02675.x DOI: https://doi.org/10.1046/j.1365-2133.1999.02675.x
Moreno-Arrones OM, Campo R del, Saceda-Corralo D, Jimenez-Cauhe J, Ponce-Alonso M, Serrano-Villar S, et al. Folliculitis decalvans microbiological signature is specific for disease clinical phenotype. J Am Acad Dermatol 2021; 85: 1355-1357.
https://doi.org/10.1016/j.jaad.2020.10.073 DOI: https://doi.org/10.1016/j.jaad.2020.10.073
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Ana Melián-Olivera, Óscar Moreno-Arrones, Patricia Burgos-Blasco, Ángela Hermosa-Gelbard, Pedro Jaén-Olasolo, Sergio Vañó-Galván, David Saceda-Corralo
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.